Saunders Michael D
Division of Gastroenterology, University of Washington Medical Center, 1959 NE Pacific Avenue, Box 356424, Seattle, WA 98195, USA.
Curr Gastroenterol Rep. 2004 Oct;6(5):410-6. doi: 10.1007/s11894-004-0059-5.
Acute colonic pseudoobstruction (ACPO) is a clinical condition of acute large bowel obstruction without mechanical blockage. ACPO occurs most often in hospitalized patients with serious underlying medical and surgical conditions. ACPO is an important cause of morbidity and mortality. The pathogenesis of ACPO is not completely understood but likely results from an imbalance in the autonomic regulation of colonic motor function. Metabolic or pharmacologic factors, as well as spinal or retroperitoneal trauma, may alter the autonomic regulation of colonic function, leading to excessive parasympathetic suppression or sympathetic stimulation. This imbalance results in colonic atony and pseudoobstruction. Early recognition and appropriate management are critical to minimizing morbidity and mortality. The mortality rate is estimated at 40% when ischemia or perforation occurs. The best documented treatment of ACPO is intravenous neostigmine, which leads to prompt decompression in the majority of patients after a single infusion. In patients failing or having contraindications to neostigmine, colonoscopic decompression is the active intervention of choice. Surgery is reserved for those with overt peritonitis or perforation.
急性结肠假性梗阻(ACPO)是一种无机械性梗阻的急性大肠梗阻临床病症。ACPO最常发生于患有严重基础内科和外科疾病的住院患者中。ACPO是发病和死亡的一个重要原因。ACPO的发病机制尚未完全明了,但可能是由于结肠运动功能自主调节失衡所致。代谢或药理因素,以及脊柱或腹膜后创伤,可能会改变结肠功能的自主调节,导致副交感神经抑制过度或交感神经刺激。这种失衡会导致结肠无张力和假性梗阻。早期识别和适当处理对于将发病率和死亡率降至最低至关重要。当发生缺血或穿孔时,死亡率估计为40%。ACPO最有文献记载的治疗方法是静脉注射新斯的明,大多数患者单次输注后即可迅速减压。对于新斯的明治疗无效或有禁忌证的患者,结肠镜减压是首选的积极干预措施。手术仅适用于有明显腹膜炎或穿孔的患者。